Profusa, Inc. Receives Nasdaq Compliance Determination
Profusa, Inc., a digital health company developing biosensor technologies, announced that it has regained compliance with Nasdaq's bid price and equity rules. The company remains under a one-year Monitoring Period during which it must maintain these standards to avoid delisting. Profusa also disclosed its option agreement to acquire G3 Vision Labs,…